¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"rate process"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • cumulative survival rate
    ´©Àû»ýÁ¸À²
  • cure rate
    Ä¡À¯À²
  • case fatality rate
    Áõ·ÊÄ¡¸í·ü
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • cause-specific rate
    ¿øÀκ°ºñÀ²
  • cerebral metabolic rate
    ³ú´ë»çÀ²
  • child death rate
    ¼Ò¾Æ»ç¸Á·ü
  • defect rate
    °áÇÔ·ü
  • death rate
    »ç¸Á·ü
  • diffusion rate
    È®»êÀ²
  • disability rate
    Àå¾ÖÀ²
  • disappearance rate
    ¼Ò½Ç·ü
  • divorce rate
    ÀÌÈ¥À²
  • dose rate
    1. ¼±·®·ü 2. Åõ¿©·®
  • dose rate effect
    ¼±·®·üÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü
  • crude birth rate
    Á¶Ãâ»ý·ü
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • crude fertility rate
    Á¶»ý½Ä·ü, Á¶¼öÅÂÀ²
  • crude natural increase rate
    Á¶ÀÚ¿¬Áõ°¡À², º¸ÅëÀÚ¿¬Áõ°¡À²
  • crude survival rate
    Á¶»ýÁ¸À²
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • cumulative incidence rate
    ´©Àû¹ß»ý·ü
  • cumulative survival rate
    ´©Àû»ýÁ¸À²
  • cure rate
    Ä¡À¯À²
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • kerma rate constant
    Ä¿¸¶À²»ó¼ö
  • mortality rate curve
    »ç¸Á·ü°î¼±
  • rate constant
    ¼Óµµ»ó¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • hebdomadal death rate
    »ýÈÄÀÏÁÖ°£»ç¸Á·ü(ÊÙË×ËÎËô).
  • high dose rate
    °í¼±·®À²
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
  • incidence rate
    ¹ßº´·ü, ½Åȯ¹ß»ý·ü
  • incidence rate
    ¹ß»ý·ü(ËÑË×Ëô).
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü.
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü(úìíìôÑá¼ã÷ëÒ).
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À².
  • postneonatal mortality rate
    ÈĽŻý¾Æ»ç¸Á·ü(Ì·ËàË×ËâË×ËÎËô).
  • pregnancy rate
    ÀÓ½ÅÀ²(ìôããëÒ).
  • prevalence [rate]
    À¯º´·ü
  • prevalence rate
    À¯º´·ü(ËôËÓËô).
  • production rate
    »ý»êÀ²
  • puerperal death rate
    »ê¿å»ç¸Á·ü (ÊÙË×ËÎËô).
  • puerperal death rate
    »êÈÄ»ç¸Á·ü,»ê¿å»ç¸Á·ü (¡­ÞÝØÌëÒ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • high dose rate
    °í¼±·®À²
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
  • incidence rate
    ¹ßº´·ü, ½Åȯ¹ß»ý·ü
  • incidence rate
    ¹ß»ý·ü(ËÑË×Ëô).
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü.
  • kerma rate constant
    Ä¿¸¶À²»ó¼ö
  • legitimate fertility rate
    À¯¹è¿ìÃâ»êÀ²(ËôËÑËí̧Ë×Ëô).
  • live birth rate
    »ý¾ÆÃâ»ý·ü,»ý»êÀ².
  • low dose rate
    Àú¼±·®À²
  • low dose rate irradiation
    Àú¼±·®À²¹æ»ç¼±Ä¡·á, -Á¶»ç
  • marriage rate
    °áÈ¥À²(Ë­Ì´Ëô).
  • maternal death rate
    ¸ð¼º»ç¸Á·ü(Ù½àõÞÝØÌëÒ).
  • maternal mortality rate
    ¸ð¼º»ç¸Á·ü(Ù½àõÞÝ ØÌëÒ). [»êºÎ]ÀÓ»êºÎ»ç¸Á·ü(ìôß§ÜþÞÝØÌëÒ).
  • maternal mortality rate
    ¸ð¼º»ç¸Á·ü(ËÎËÛË× ËÎËô).»êºÎÀÓ»êºÎ»ç¸Á·ü(ËöË×ËÓË×ËÎËô).
  • maximal growth rate
    ÃÖ´ëÁõ½ÄÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
BFR biologic false reaction; blood flow rate; bone formation rate; buffered Ringer [solution]
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
HR heart rate; hemorrhagic retinopathy; high resolution; higher rate; histamine receptor; hormonal resp...
MFR mean flow rate; mucus flow rate
MHR major histocompatibility region; malignant hyperthermia resistance; maternal heart rate; maximal hea...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
FR Firing Rate
FFR Fluid Filtration Rate
FCR Fractional catabolic rate
FSR Fractional protein synthesis rate
FSR Fractional synthesis rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nasal process of the frontal bone
    ÀüµÎ°ñ ºñºÎ
  • neuro-chemical process
    ½Å°æ È­ÇÐÀû °úÁ¤
  • neuropathic process
    ½Å°æº´Áõ¼º °úÁ¤
  • nitrifying process
    ÁúÈ­ °úÁ¤
  • normal eruption process
    Á¤»ó ¸ÍÃâ °úÁ¤
  • notochordal process
    ô»è µ¹±â, »èµ¹±â, Ãà»è µ¹±â
  • opened vaginal process of testis
    °íȯÁý µ¹±â ¿­¸²Áõ
  • osteolytic process
    °ñ ¿ëÇØ °úÁ¤
  • palatal process
    ±¸°³ µ¹±â
  • paramastoid process
    ²ÀÁö¿· µ¹±â
    mastoid
  • peripheral dendritic process
    ¸»ÃÊ °¡Áö µ¹±â¼º µ¹±â
  • peripheral process
    ¸»ÃÊ µ¹±â
  • peripheral sympathetic process
    ¸»ÃÊ ±³°¨ °úÁ¤
  • physical process
    ¹°¸®Àû ó¸® °úÁ¤
  • posterior clinoid process
    µÚ ħ»ó µ¹±â, ÈÄ»ó µ¹±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
instantaneous rate <epidemiology> In a short time interval (e.g a week), the number of events (e.g. Births in the UK) taking place during the interval is approximately proportional to the length of the interval. The constant of proportionality is the rate at which these events occur. This argument becomes more and more exact as the length of the time interval becomes shorter and shorter. When the time interval has shrunk to an instant, the rate has become an `instantaneous rate'. A bad term; just call it a rate.
(05 Dec 1998)
integrated rate expression An equation of a chemical or enzyme-catalyzed reaction for the entire progress curve.
(05 Mar 2000)
overall response rate <pharmacology> Sum of complete and partial tumour responses seen in a study, divided by the number of evaluable patients.
(05 Jan 1998)
total fertility rate <epidemiology> The number of children an average women would have assuming that she lives her full reproductive lifetime.
(05 Dec 1998)
erythrocyte sedimentation rate <investigation> A test that measures the rate at which red blood cells settle through a column of liquid. A non-specific index of inflammation.
Acronym: ESR
(11 Nov 1997)
fatality rate The death rate observed in a designated series of persons affected by a simultaneous event such as a disaster.
(05 Mar 2000)
uniform rate hypothesis <biology> This states that any two evolving organismal lineages diverge from a common ancestor at a constant rate with respect to each other.
(09 Oct 1997)
five year survival rate The proportion of patients still alive five years after a diagnosis or form of treatment is completed. Usually applied to statistics of survival of cancer patients, since after five years, recurrences are much less likely to occur.
(05 Mar 2000)
fixed-rate pacemaker An artificial pacemaker that emits electrical stimuli at a constant frequency.
(05 Mar 2000)
fixed rate pulse generator A generator in which the rate of discharge is independent of the natural activity of the heart.
Synonym: fixed rate pulse generator.
(05 Mar 2000)
flow rate The amount of water that moves through an area (usually pipe) in a given period of time.
(05 Dec 1998)
foetal death rate The number of foetal deaths divided by the sum of live births and foetal deaths occurring in the same population during the same time period.
Synonym: stillbirth rate.
(05 Mar 2000)
foetal heart rate In the foetus, the number of heart beats per minute, normally 120 to 160.
(05 Mar 2000)
foetal mortality rate <epidemiology> The ratio of foetal deaths divided by the sum of the births (the live births + the foetal deaths) in that year. In the United States, the foetal mortality rate plummeted from 19.2 per 1,000 births in 1950 to 9.2 per 1,000 births in 1980.
(12 Dec 1998)
5-year relative survival rate <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer.
(16 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á